RXO
About: RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the largest component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement our truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operating segment operate within the transportation industry and in primarily the same geography North America.
Employees: 8,432
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
338% more call options, than puts
Call options by funds: $4.84M | Put options by funds: $1.1M
161% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 23
84% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 56
43% more capital invested
Capital invested by funds: $3.18B [Q2] → $4.56B (+$1.38B) [Q3]
14% more funds holding
Funds holding: 242 [Q2] → 275 (+33) [Q3]
0.31% less ownership
Funds ownership: 103.47% [Q2] → 103.16% (-0.31%) [Q3]
17% less funds holding in top 10
Funds holding in top 10: 6 [Q2] → 5 (-1) [Q3]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
8 analyst ratings
Stifel J. Bruce Chan 29% 1-year accuracy 9 / 31 met price target | 25%upside $27 | Hold Maintained | 23 Jan 2025 |
Barclays Brandon Oglenski 61% 1-year accuracy 41 / 67 met price target | 39%upside $30 | Overweight Maintained | 17 Jan 2025 |
Jefferies Stephanie Moore 82% 1-year accuracy 27 / 33 met price target | 39%upside $30 | Buy Maintained | 10 Jan 2025 |
Wells Fargo Christian Wetherbee 57% 1-year accuracy 24 / 42 met price target | 29%upside $28 | Equal-Weight Maintained | 7 Jan 2025 |
Goldman Sachs Jordan Alliger 47% 1-year accuracy 7 / 15 met price target | 34%upside $29 | Neutral Reinstated | 18 Nov 2024 |
Financial journalist opinion
Based on 7 articles about RXO published over the past 30 days